Submission is open for late-breaking abstracts only.
Deadline: 24 April 2023

Abstracts are accepted under the “late-breaking” category only if they meet the following criteria:
  • The research must be new and of sufficient scientific importance to merit special consideration after the standard abstract deadline.
  • Abstracts should describe either large clinical studies or high-impact translational research that could not be completed prior to the regular submission deadline.
  • Clinical studies must be prospective in design.
  • Late-breaking abstracts must not be a revision of an abstract submitted prior to the submission deadline.

Professionals and trainees involved with prenatal diagnosis and therapy are invited to submit an abstract. You do not need to be an ISPD member to submit an abstract.

Abstract-based presentations will be given during plenary or concurrent sessions. Notification of acceptance will be made in May, following peer review of all submissions.

Topic categories are listed at the bottom of this page.

Abstract Types

Abstracts will be accepted for the following formats. Abstract authors may opt to be considered for one or both formats. Presenters of accepted abstracts are expected to register to attend the conference, at least for the day of their presentation.

Oral Presentation: a standard scientific abstract considered for either an oral presentation, or a poster presentation. Authors may indicate whether they want to be considered for either format, or only for oral presentation. These submissions must include complete objective, methods, results, and conclusions sections. All oral presentations must be given in person in Edinburgh.

Scientific Poster: a standard scientific abstract submission for a poster presentation. These submissions must include complete objective, methods, results, and conclusions sections. Poster presenters who are attending in person will present a physical poster as well as provide a PDF file for the virtual platform. Virtual attendees will present their posters as PDF files, and authors will have the option to record a brief video. There will be an attended poster session for in-person presenters as well as opportunities for virtual presenters to answer questions from the audience.

All submissions that are accepted and presented at the conference will be published in a special edition of Prenatal Diagnosis.
See previously published abstracts.


Abstract Categories

Abstract submissions are encouraged in the following categories.

  • Prenatal diagnosis and screening for cytogenomic abnormalities
  • Epigenetics and development
  • Fetal and placental development and pathology
  • Fetal imaging: Ultrasound and Magnetic Resonance Imaging
  • Fetal medical and surgical therapy
  • Global issues in prenatal diagnosis and screening
  • Noninvasive prenatal diagnosis and screening
  • Pre-implantation genetic testing
  • Prenatal diagnosis and screening for single gene disorders
  • Prenatal genetic counseling
  • Prenatal prediction of adverse pregnancy outcomes (e.g pre-eclampsia / preterm labour / growth restriction and stillbirth)
  • Psychosocial, legal and ethical issues in prenatal screening and diagnosis
  • Reproductive genomics, metabolomics and proteomics
  • Teratogens and Fetal infection
  • Multiple Pregnancy
Published abstracts from previous years are available through the Downloads page.